HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

VCRP comments

This article was originally published in The Rose Sheet

Executive Summary

FDA solicits written comments on the Cosmetic Product Voluntary Reporting Program for a 60-day period. The announcement was published in the Federal Register Aug. 9. VCRP was reinstated earlier in 1999 following Congress' appropriation of an additional $2.5 mil. for FDA's cosmetics program (1"The Rose Sheet" Jan. 11, p. 3). The program was suspended during FY 1998 due to lack of funding. The Cosmetic, Toiletry and Fragrance Association formed an industry task force to review a range of options for improving Part II of the program, the registration of product formulation data (2"The Rose Sheet" April 26, In Brief)
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

RS007034

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel